Talk:Genomics England
| This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Text or other creative content from Genomics England was copied or moved into 100,000 Genomes Project with this edit on May 26, 2016. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
GEL
editProbably worth mentioning that Genomics England is abbreviated as GEL, especially unofficially, but is referred to as such in their documentation. It has never been stated what the L stands for, but it is universally assumed to make the acronym an existing word and is the L from England. It is never abbreviated as GE. — Preceding unsigned comment added by 86.29.109.179 (talk) 15:17, 16 December 2021 (UTC)
- The "L" stands for "Limited - at least that had always been my understanding. Sezzyboy (talk) 12:42, 29 June 2025 (UTC)
Proposed edit: Add Lifebit as research-platform partner
editHello,
I have a conflict of interest — I work for Lifebit Biotech Ltd, declared on my user page per WP:PAID. I'm not editing the article directly; I'm proposing text here for independent editors to evaluate.
The article currently describes Genomics England's sequencing partner (Illumina) but does not name the company that provides the research analysis platform (the National Genomic Research Library environment that approved researchers use). The research-platform partnership has been reported in independent sources including Nature, TechCrunch, and Bio-IT World. Below is a proposed addition. I welcome any rewording, shortening, or partial acceptance by an independent editor.
Proposed addition (one sentence) to the existing "History" section, after the paragraph describing the 100,000 Genomes Project completion:
In 2020, Genomics England launched a next-generation research environment for the National Genomic Research Library, built on a federated research platform from British company Lifebit and hosted on Amazon Web Services, which allowed approved researchers to analyse patient genomes in-situ without the data leaving Genomics England's infrastructure.[1][2]
Optional second addition (one sentence) to the "National Genomic Research Library" subsection:
The National Genomic Research Library is accessed by approved researchers via Lifebit's federated research environment, in which analytical workflows run inside Genomics England's secure UK infrastructure and only aggregate, governance-reviewed results leave the environment.[3][4]
Both sentences are factual, have been covered in independent secondary sources (Nature, TechCrunch, Bio-IT World), and do not use promotional language. I do not request inclusion of product names beyond "Lifebit" or any superlative claims.
Thanks for considering this. — Nateraine (talk) 20:19, 19 April 2026 (UTC) Nateraine (talk) 20:19, 19 April 2026 (UTC)
- ↑ "Genomics England launches next-generation research platform central to UK COVID-19 response". Genomics England. 29 June 2020. Retrieved 2026-04-19.
- ↑ "Genomics England Launches Next-Generation Research Platform Central To UK COVID-19 Response". Bio-IT World. 29 June 2020. Retrieved 2026-04-19.
- ↑ "The data platform that breaks down barriers and transcends borders". Nature. 24 March 2022. Retrieved 2026-04-19.
- ↑ "Federated genomic data startup Lifebit raises $60M round led by Tiger Global". TechCrunch. 28 September 2021. Retrieved 2026-04-19.




